Urticaria Facticia Treatment With Omalizumab (UFO)

计划入组 61 人 · 首次发布于 2014 年 6 月 20 日

The UFO (Ultra Processed Foods in Obesity) Project

计划入组 200 人 · 首次发布于 2022 年 9 月 26 日

A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

计划入组 108 人 · 首次发布于 2022 年 2 月 1 日

BG505-MD39.3

BG505 MD39.3 gp151

BG505 MD39.3 mRNA

JOHN SAPP

United States

Uro Medical Corporation

United States

EDP Biotech Corporation

United States

Accelerated Manufacturing Platform Enables Rapid HIV Vaccine Production for Clinical Trials

Uvax Bio's HIV-1 Vaccine Candidate Shows Promising Early Results in Phase 1 Trial

Weill Cornell Medicine Receives $20.8 Million NIH Grant to Develop Childhood HIV Vaccine